ScientiaLux
Index
QF-Pro Home › QF-Pro Glossary › FLIM
Core Technology — Step 3 of 5
1Fluorescence Lifetime
2FRET
3FLIM
4iFRET
5QF-Pro
Previous
FRET Next
iFRET
Imaging Modality

FLIM

An intensity-independent imaging modality that measures the time a fluorophore remains in its excited state–enabling quantitative FRET detection unaffected by protein expression levels.

View
Definition
Fluorescence LifetimeLoading... Imaging Microscopy measures how long a fluorophoreLoading... remains in its excited state before returning to ground state by photon emission. This intrinsic property (typically 1–10 nanoseconds) is independent of fluorophore concentration, excitation intensity, and photobleaching–making it ideal for quantitative FRETLoading... measurement in clinical samples with variable protein expression.
Video Segments
Fluorescence Lifetime & Why It Matters
Primary
Violet 3.0: Benchtop FLIM Microscope
Primary
Related Segments
Consecutive Tissue Slices: Two-Slide Method
Related
Lifetime measurement
1–10 ns range
Intensity-independent
Robust to expression variation
High-throughput compatible
Violet 3.0 FLIM system
FRET detection via τ change
Donor quenching

Time-Domain vs Frequency-Domain

TimeLoading...-domain FLIM uses pulsed excitation and directly measures photon arrival times using time-correlated single photon countingLoading... (TCSPC). This provides excellent lifetime resolution but traditionally requires longer acquisition times.

Frequency-domain FLIM modulates excitation intensity sinusoidally and measures the phase shift and demodulation of emitted fluorescence. This approach–used by the Violet 3.0Loading... system to read QF-ProLoading... FRET signals–enables high-throughput acquisition compatible with clinical workflows.

Both approaches yield the same fundamental measurement: the characteristic decay time of the fluorophore, which decreases when FRET occurs.

Simplified

Two Approaches:

• Time-domain: Brief light pulse, then measure how long the glow takes to decay

• Frequency-domain: Oscillating light, then measure phase shift and amplitude changes

Both ultimately measure the same thing: fluorescence lifetime.

Why Lifetime Matters for Clinical FRET

In clinical tissue samples, protein expression varies enormously between patients and within tumors. Intensity-based FRET measurements are confounded by this variability–high intensity could mean high expression, high FRET efficiencyLoading..., or both.

Lifetime measurement eliminates this ambiguity. A fluorophore with a 2.0 ns lifetime will always have a 2.0 ns lifetime regardless of how many molecules are present. When FRET occurs, the donor lifetime decreases–and this decrease is the same whether the sample contains abundant protein or sparse protein at an immune synapse.

This intensity-independence is precisely why FLIM-FRET succeeds where expression-based biomarkers fail: it detects biologically decisive interactions at low expression levels.

Simplified

The Key Advantage: Lifetime is an intrinsic property of the fluorophore, not affected by how much is present or how bright the lamp is.

Clinical Impact: This makes measurements more reproducible between samples and between labs—essential for clinical diagnostics.

Clinical Implementation

  • The Violet 3.0Loading... FLIM system reads QF-ProLoading... FRET reagent signals using frequency-domain FLIM for high-throughput detection
  • Acquisition times of ~16 seconds per field enable clinically practical workflows
  • Automated ROI detection eliminates operator subjectivity in lifetime measurement

Connected Terms

Share This Term
Term Connections